We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$138M
AUM Growth
-$9.31M
Cap. Flow
-$9.71M
Cap. Flow %
-7.03%
Top 10 Hldgs %
24.49%
Holding
191
New
28
Increased
25
Reduced
77
Closed
34

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$935K
2
MET icon
MetLife
MET
+$903K
3
FOX icon
Fox Class B
FOX
+$867K
4
CAG icon
Conagra Brands
CAG
+$770K
5
ELAN icon
Elanco Animal Health
ELAN
+$663K

Sector Composition

Rank Sector Weight
1 Healthcare 19.04%
2 Consumer Staples 15.56%
3 Industrials 14.75%
4 Technology 13.52%
5 Financials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
76
Union Pacific
UNP
$169B
$640K 0.46%
3,949
-1,218
-24% -$205K
PH icon
77
Parker-Hannifin
PH
$117B
$638K 0.46%
3,535
-225
-6% -$38.3K
MPC icon
78
Marathon Petroleum
MPC
$115B
$636K 0.46%
10,475
-7,775
-43% -$410K
DRI icon
79
Darden Restaurants
DRI
$23.7B
$629K 0.46%
5,323
+1,900
+56% +$232K
BALL icon
80
Ball Corp
BALL
$16.1B
$619K 0.45%
+8,497
New +$633K
COR
81
DELISTED
Coresite Realty Corporation
COR
$612K 0.44%
+5,021
New +$575K
SBUX icon
82
Starbucks
SBUX
$110B
$606K 0.44%
6,850
+1,225
+22% +$114K
JNPR
83
DELISTED
Juniper Networks
JNPR
$598K 0.43%
24,150
-4,450
-16% -$112K
GILD icon
84
Gilead Sciences
GILD
$181B
$595K 0.43%
9,380
-50
-0.5% -$3.27K
WFC icon
85
Wells Fargo
WFC
$271B
$583K 0.42%
11,550
-700
-6% -$33K
CFG icon
86
Citizens Financial Group
CFG
$29.6B
$582K 0.42%
16,445
-850
-5% -$29.7K
AMD icon
87
Advanced Micro Devices
AMD
$823B
$574K 0.42%
+19,800
New +$621K
EA
88
DELISTED
Electronic Arts
EA
$570K 0.41%
5,825
-2,600
-31% -$244K
EMR icon
89
Emerson Electric
EMR
$82B
$547K 0.4%
8,183
-225
-3% -$14.1K
LNG icon
90
Cheniere Energy
LNG
$56B
$530K 0.38%
8,400
-850
-9% -$54.4K
AMN icon
91
AMN Healthcare
AMN
$1.32B
$515K 0.37%
8,955
-10,994
-55% -$608K
AMZN icon
92
Amazon
AMZN
$2.68T
$502K 0.36%
+5,780
New +$536K
KSU
93
DELISTED
Kansas City Southern
KSU
$493K 0.36%
3,707
-2,647
-42% -$330K
V icon
94
Visa
V
$701B
$492K 0.36%
2,862
FDX icon
95
FedEx
FDX
$73B
$491K 0.36%
3,370
-1,500
-31% -$242K
APD icon
96
Air Products & Chemicals
APD
$64.7B
$488K 0.35%
+2,200
New +$495K
MS icon
97
Morgan Stanley
MS
$324B
$485K 0.35%
11,375
+1,000
+10% +$42.7K
GSK icon
98
GSK
GSK
$100B
$482K 0.35%
9,040
-320
-3% -$16.5K
TMO icon
99
Thermo Fisher Scientific
TMO
$237B
$481K 0.35%
+1,650
New +$472K
BEAT
100
DELISTED
BioTelemetry, Inc.
BEAT
$476K 0.34%
11,675
+275
+2% +$11.9K

Similar funds

New England Research & Management's Q3 2019 Portfolio in Review

As of Q3 2019, New England Research & Management held 191 positions worth $138M, down 6.3% from $147M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management withdrew a net $9.71M in Q3 2019, closing 34 positions and reducing 77 holdings. Its most notable exit was Amgen, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, New England Research & Management opened a new position in Tyson Foods worth $948K.

  • New England Research & Management's largest Q3 2019 buy was Tyson Foods: 11,000 shares worth $948K.
  • New England Research & Management added most to Elanco Animal Health in Q3 2019, an estimated $663K increase.
  • New England Research & Management's biggest Q3 2019 reduction was Estee Lauder, cutting an estimated $1.41M.
  • New England Research & Management fully exited Amgen in Q3 2019, selling an estimated $1.8M.
  • New England Research & Management's ten largest holdings make up 24% of its $138M portfolio in Q3 2019.
  • New England Research & Management opened 28 new positions and closed 34 in Q3 2019.
  • New England Research & Management's portfolio value fell 6.3% quarter-over-quarter to $138M.

Based on New England Research & Management's 13F filing for Q3 2019, filed 4 Nov 2019.